Results 171 to 180 of about 9,225,670 (325)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it? [PDF]

Reumatologia, 2021
Kucharz EJ, Kotulska-Kucharz A.
europepmc   +1 more source

Recent topic.10.Demyelinate disease.

, 1992
西谷 裕
openalex   +2 more sources

Minimal Clinically Important Differences in Measuring Treatment Effects in CIDP: History, Current Use, Limitations, and Prospects

Muscle &Nerve, Volume 72, Issue 5, Page 1042-1051, November 2025.
ABSTRACT Outcome measures are essential for evaluating treatment effects and disease progression in chronic inflammatory demyelinating polyneuropathy (CIDP). The concept of the minimal clinically important difference (MCID), which represents the smallest change in a measure deemed clinically meaningful, has become increasingly important in CIDP ...
Yusuf A. Rajabally, Kabir K. Nazeer, Young Gi Min   +2 more
wiley   +1 more source

Biological aging of CNS-resident cells alters the clinical course and immunopathology of autoimmune demyelinating disease. [PDF]

JCI Insight, 2022
Atkinson JR, Jerome AD, Sas AR, Munie A, Wang C, Ma A, Arnold WD, Segal BM.   +7 more
europepmc   +1 more source

The role of growth factors as a therapeutic approach to demyelinating disease

Experimental Neurology, 2016
Yang-yang Huang, C. Dreyfus
semanticscholar   +1 more source

Autonomy in children and adolescents with visual impairment: Validation of the Visual Impairment Developmental Autonomy scale

Developmental Medicine &Child Neurology, Volume 67, Issue 11, Page 1472-1481, November 2025.
This original article is commented by Matsuba on pages 1378–1379 of this issue. Abstract Aim To validate the Visual Impairment Developmental Autonomy (VIDA) scale, a questionnaire to assess the autonomy level of children with visual impairment. Method The primary outcome measures included internal consistency, convergent validity, cross‐informant ...
Federica Morelli, Serena Grumi, Guido Catalano, Ilaria Scognamillo, Maria Eleonora Reffo, Roberta Zumiani, Sandra Strazzer, Elena Cocchi, Livio Provenzi, Sabrina Signorini, The VIDA Group, Elena Saligari, Eleonora Mascherpa, Daria Paini, Francesco De Cortes, Antonella Luparia, Elena Mercuriali, Nadia Sartori, Rossella Lavatelli, Luca Santini   +19 more
wiley   +1 more source

Copper Deficiency-Induced Neuropathy After Bariatric Surgery Disguised as Demyelinating Disease: A Case Report. [PDF]

Cureus, 2022
Amin A, Khoury NC, Lacayo M, Kostanyan S.   +3 more
europepmc   +1 more source

Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.

Journal of Autoimmunity, 2019
Yhojan Rodríguez, Nikhil Vatti, C. Ramírez-Santana, Christopher Chang, Oscar Mancera-Páez, M. Gershwin, J. Anaya   +6 more
semanticscholar   +1 more source

Blurred by a "Puff of Smoke"-A Case-Based Review on the Challenging Recognition of Coexisting CNS Demyelinating Disease and Moyamoya Angiopathy. [PDF]

Int J Mol Sci
Canavero I, Rifino N, Antozzi C, Caldiera V, Colombo E, Carrozzini T, Ganci G, Ferroli P, Acerbi F, Storti B, Boncoraglio GB, Potenza A, Pollaci G, Gorla G, Ciceri E, De Marco P, Gatti L, Bersano A.   +17 more
europepmc   +1 more source

A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis. [PDF]

Neurol Neuroimmunol Neuroinflamm, 2021
Money KM, Mahatoo A, Samaan S, Anand P, Baber U, Bailey M, Bakshi R, Bouley A, Bower A, Cahill J, Houtchens M, Katz J, Lathi E, Levit E, Longbrake EE, McAdams M, Napoli S, Raibagkar P, Wade P, Sloane JA.   +19 more
europepmc   +1 more source